Biotech startup Jaguar Gene Therapy has raised $139 million in new funding from high-profile backers Eli Lilly and ARCH Venture Partners, which joined venture founder Deerfield Management in closing a Series B round announced Tuesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,